Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Neurogastroenterol Motil. 2014 Jul 20;26(9):1285–1297. doi: 10.1111/nmo.12391

Table 2a. Clinical Characteristics of 17 patients with immunotherapy-responsive gastrointestinal dysmotility.

Patient Age/Sex Gastrointestinal symptoms Personal (or family) Hx
of autoimmunity
Feeding
Route†
Dysautonomia
type
BMI Weight loss
(Kg)
Dysphagia Pain Early satiety Nausea/
vomiting
Bloating Diarrhea Constipation
1 65/F 20.1 Graves' disease Oral Diffuse
2 49/F 26.12 Celiac disease Oral Multifocal
3 57/F 21.2 ✓ ( 9.1) Hashimoto thyroiditis Oral Limited
4 19/F 17.4 ✓ (12.7) Celiac disease Enteral Multifocal
5* 76/M 17.7 ✓ (22.7) - Oral Diffuse
6 71/F 20.6‡ ✓ (20.5) - Oral Diffuse
7 36/F 24.3 - Oral Limited
8 26/F 16.2 ✓ (13.6) (Maternal hypothyroidism) Oral Limited
9* 22/F 18.3 ✓ (22.7) - Parenteral Limited
10 30/F 17.4 ✓ (5) - Enteral Multifocal
11 34/F 19.9 ✓ (6) - Oral Multifocal
12 44/F - (Maternal diabetes) Oral Diffuse
13 43/F 15.8 ✓ (21.4) Lupus Enteral Multifocal
14 34/F 23.5 ✓ (6.8) Lupus, alopecia areata Oral Multifocal
15 16/F 16.7 ✓ (4.1) - Enteral Limited
16 38/F 18.3 ✓ (18.2) (crohn's disease, lupus) Oral Multifocal
17 33/F 33.1 Type 1 diabetes, Hypothyroid Parenteral Limited